Sanofi is a French healthcare company founded in 2004 and with headquarters in Paris. Sanofi has an overall employee count of 1,00,000 plus.
Sanofi is ranked 241 in the 2015 Fortune Global 500 Companies list and is ranked 89 in the Forbes Global 2000, 2015. Sanofi has annual revenue of $39.393 billion, R & D expenditure of $5.743 billion and a basic EPS of $3.706, making it the sixth top global pharmaceutical company in the world.
The business areas of Sanofi are focused on attaining three targets:
(a) Sustaining leadership, through formulations for diabetic and cardiovascular disorders, rare diseases, emerging markets and vaccines,
(b) Building competitive positions, through development and commercialization of drugs for multiple sclerosis, oncology, immunology and circulation of consumer healthcare products and
(c) Exploring strategic options, through animal health and generics solutions.
As of April 2016, Sanofi has 46 pharmaceutical entities and vaccines in clinical development with 15 of them in Phase III trials. 1Q sales revenue 2016 was $8.5 billion, a 0.7% increase for 1Q sales, 2015, indicating the company’s sustainable growth.